Literature DB >> 15896196

NPC1 late endosomes contain elevated levels of non-esterified ('free') fatty acids and an abnormally glycosylated form of the NPC2 protein.

Fannie W Chen1, Ronald E Gordon, Yiannis A Ioannou.   

Abstract

NPC (Niemann-Pick type C) disease is a rare lipidosis characterized by the accumulation of LDL (low-density lipoprotein)-derived non-esterified cholesterol in the E/L (endosomal/lysosomal) system. The gene products that are responsible for the two NPC complementation groups are distinct and dissimilar, yet their cellular and disease phenotypes are virtually indistinguishable. To investigate the relationship between NPC1 and NPC2 and their potential role in NPC disease pathogenesis, we have developed a method for the rapid and efficient isolation of late endocytic vesicles from mouse liver by magnetic chromatography. Late endosomes from Wt (wild-type) and NPC1 mice were found to differ not only in their cholesterol and sphingomyelin content, as expected, but also in their non-esterified ('free') fatty acid content, with NPC1 vesicles showing an approx. 7-fold increase in non-esterified fatty acid levels compared with Wt vesicles. Furthermore, we show that the NPC2 protein is in an incompletely deglycosylated form in NPC1 late endosomes by a mechanism that is specific to the NPC2 protein and not a global aberration of protein glycosylation/deglycosylation or trafficking, since NPC2 secreted from NPC1 cells is indistinguishable from that secreted from Wt cells. Also, a greater proportion of the normally soluble cellular NPC2 protein partitions with detergent-insoluble late endosomal internal membrane domains in NPC1 vesicles. In addition, we show that, although a small amount of the NPC2 protein associates with these membranes in Wt vesicles, this localization becomes much more pronounced in NPC1 vesicles. These results suggest that the function of the NPC2 protein may be compromised as well in NPC1 endosomes, which might explain the paradoxical phenotypic similarities of the two NPC disease complementation groups.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15896196      PMCID: PMC1198935          DOI: 10.1042/BJ20050236

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  59 in total

1.  Proteomics of rat liver Golgi complex: minor proteins are identified through sequential fractionation.

Authors:  R S Taylor; C C Wu; L G Hays; J K Eng; J R Yates; K E Howell
Journal:  Electrophoresis       Date:  2000-10       Impact factor: 3.535

2.  Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop.

Authors:  G Millat; C Marçais; C Tomasetto; K Chikh; A H Fensom; K Harzer; D A Wenger; K Ohno; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-05-01       Impact factor: 11.025

3.  The steroidogenic acute regulatory protein homolog MLN64, a late endosomal cholesterol-binding protein.

Authors:  F Alpy; M E Stoeckel; A Dierich; J M Escola; C Wendling; M P Chenard; M T Vanier; J Gruenberg; C Tomasetto; M C Rio
Journal:  J Biol Chem       Date:  2000-10-26       Impact factor: 5.157

4.  Cessation of rapid late endosomal tubulovesicular trafficking in Niemann-Pick type C1 disease.

Authors:  M Zhang; N K Dwyer; D C Love; A Cooney; M Comly; E Neufeld; P G Pentchev; E J Blanchette-Mackie; J A Hanover
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Niemann-Pick disease type C: spectrum of HE1 mutations and genotype/phenotype correlations in the NPC2 group.

Authors:  G Millat; K Chikh; S Naureckiene; D E Sleat; A H Fensom; K Higaki; M Elleder; P Lobel; M T Vanier
Journal:  Am J Hum Genet       Date:  2001-09-20       Impact factor: 11.025

6.  Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia.

Authors:  Joanna P Davies; Catherine Scott; Kimihiko Oishi; Anastasia Liapis; Yiannis A Ioannou
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

7.  Identification of HE1 as the second gene of Niemann-Pick C disease.

Authors:  S Naureckiene; D E Sleat; H Lackland; A Fensom; M T Vanier; R Wattiaux; M Jadot; P Lobel
Journal:  Science       Date:  2000-12-22       Impact factor: 47.728

8.  Sterol-modulated glycolipid sorting occurs in niemann-pick C1 late endosomes.

Authors:  M Zhang; N K Dwyer; E B Neufeld; D C Love; A Cooney; M Comly; S Patel; H Watari; J F Strauss; P G Pentchev; J A Hanover; E J Blanchette-Mackie
Journal:  J Biol Chem       Date:  2000-10-13       Impact factor: 5.157

9.  Dynamic movements of organelles containing Niemann-Pick C1 protein: NPC1 involvement in late endocytic events.

Authors:  D C Ko; M D Gordon; J Y Jin; M P Scott
Journal:  Mol Biol Cell       Date:  2001-03       Impact factor: 4.138

10.  Depletion of rafts in late endocytic membranes is controlled by NPC1-dependent recycling of cholesterol to the plasma membrane.

Authors:  S Lusa; T S Blom; E L Eskelinen; E Kuismanen; J E Månsson; K Simons; E Ikonen
Journal:  J Cell Sci       Date:  2001-05       Impact factor: 5.285

View more
  29 in total

1.  N-glycome of the Lysosomal Glycocalyx is Altered in Niemann-Pick Type C Disease (NPC) Model Cells.

Authors:  Marko Kosicek; Ivan Gudelj; Anita Horvatic; Tanja Jovic; Frano Vuckovic; Gordan Lauc; Silva Hecimovic
Journal:  Mol Cell Proteomics       Date:  2018-01-24       Impact factor: 5.911

2.  The Niemann-Pick C1 gene is downregulated in livers of C57BL/6J mice by dietary fatty acids, but not dietary cholesterol, through feedback inhibition of the SREBP pathway.

Authors:  David Jelinek; Joseph J Castillo; Lisa M Richardson; Li Luo; Randall A Heidenreich; William S Garver
Journal:  J Nutr       Date:  2012-09-18       Impact factor: 4.798

3.  Abnormal LAMP1 glycosylation may play a role in Niemann-Pick disease, type C pathology.

Authors:  Niamh X Cawley; Caitlin Sojka; Antony Cougnoux; Anna T Lyons; Elena-Raluca Nicoli; Christopher A Wassif; Forbes D Porter
Journal:  PLoS One       Date:  2020-01-30       Impact factor: 3.240

4.  Down-regulation of the ATP-binding cassette transporter 2 (Abca2) reduces amyloid-β production by altering Nicastrin maturation and intracellular localization.

Authors:  Vasiliki Michaki; Francesc X Guix; Krist'l Vennekens; Sebastian Munck; Colin Dingwall; John B Davis; Danyelle M Townsend; Kenneth D Tew; Fabian Feiguin; Bart De Strooper; Carlos G Dotti; Tina Wahle
Journal:  J Biol Chem       Date:  2011-11-15       Impact factor: 5.157

Review 5.  Niemann-Pick C2 (NPC2) and intracellular cholesterol trafficking.

Authors:  Judith Storch; Zhi Xu
Journal:  Biochim Biophys Acta       Date:  2009-02-13

6.  Role of endosomal membrane lipids and NPC2 in cholesterol transfer and membrane fusion.

Authors:  Misbaudeen Abdul-Hammed; Bernadette Breiden; Matthew A Adebayo; Jonathan O Babalola; Günter Schwarzmann; Konrad Sandhoff
Journal:  J Lipid Res       Date:  2010-02-23       Impact factor: 5.922

7.  Cyclodextrin induces calcium-dependent lysosomal exocytosis.

Authors:  Fannie W Chen; Chunlei Li; Yiannis A Ioannou
Journal:  PLoS One       Date:  2010-11-29       Impact factor: 3.240

8.  Impaired lysosomal trimming of N-linked oligosaccharides leads to hyperglycosylation of native lysosomal proteins in mice with alpha-mannosidosis.

Authors:  Markus Damme; Willy Morelle; Bernhard Schmidt; Claes Andersson; Jens Fogh; Jean-Claude Michalski; Torben Lübke
Journal:  Mol Cell Biol       Date:  2010-01       Impact factor: 4.272

9.  The genetics of childhood obesity and interaction with dietary macronutrients.

Authors:  William S Garver; Sara B Newman; Diana M Gonzales-Pacheco; Joseph J Castillo; David Jelinek; Randall A Heidenreich; Robert A Orlando
Journal:  Genes Nutr       Date:  2013-03-08       Impact factor: 5.523

10.  Niemann-Pick type C disease proteins: orphan transporters or membrane rheostats?

Authors:  Andrew B Munkacsi; Anthony F Porto; Stephen L Sturley
Journal:  Future Lipidol       Date:  2007-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.